Therapeutic vaccination of solid tumors with uracil auxotrophs converts tolerogenic tumor microenvironments into immune stimulatory microenvironments in aggressive models of murine pancreatic cancer, melanoma, and ovarian cancer through the stimulation of tumor-specific CD8+ T cell populations [15,16,19]. The gene discussed is CD8A; the disease is pancreatic neoplasm.